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Background 
•  Emergence of a subgroup of head and neck cancers that 
are virally mediated 
•  Patient presentation: 
–  large nodal size 
–  younger  
–  associated with a lower exposure to tobacco and alcohol 
–  more favourable prognosis  
•  Radioresponsive disease 
•  Adaptive radiotherapy: treatment response results in 
need for re-planning during radiotherapy in a subset of 
patients 
 
(Lassen P. Radiother Oncol. 2010;95(3):371-380.) 
 
!Planning CT 
Re-CT at #19 of treatment 
Aims 
•  Determine predictive factors and 
thresholds for need of re-planning 
•  Begin this process using retrospective 
data 
 
Methodology 
•  Inclusion criteria: 
–  Study period 2005-2010 presenting at Princess 
Alexandra Hospital 
–  Virally-mediated, node positive head and neck 
cancer (EBV positive or HPV positive) 
–  Received curative intent RT   
•  Patient demographics recorded including size of 
dominant node at diagnosis 
Methodology 
•  If a re-CT was performed, the reason for the re-
CT was evaluated    
•  The justification for re-CT was assessed using 
three categories:  
–  tumour and/or nodal regression  
–  weight loss  
–  combination of these factors 
Results 
•  Reviewed 121 patients from total of 221 treated 
during study period 
•  16 nasopharyngeal and 105 oropharyngeal 
tumours reviewed 
•  25 (21%) patients underwent a re-planning CT at 
a median of 22 (range, 0-29) fractions  
•  16 (13.2%) had re-plan generated 
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Results 
•  Based on evaluation and clinical experience, 
patients were placed into 3 groups according to 
maximum dominant nodal size at diagnosis:  
–  Group 1 - ≤35mm   
–  Group 2 - 36-45mm  
–  Group 3 - ≥46mm 
•  Took into consideration reasonably large 
standard deviations obtained  
Specific patient characteristics for those that had re-planning scan 
Majority due to 
both tumour 
regression and  
weight loss  
44.5mm 
32mm 
Box and whisker plot 
Results 
•  Applying these groups to the retrospective data, 
re-planning CTs were performed:  
–  Group 1 (≤35mm) - 8/68 patients (11.8%)  
–  Group 2 (36-45mm) - 4/28 patients (14.3%)  
–  Group 3 (≥46mm) - 13/25 patients (52%) 
•  Sample size did not allow statistical analysis to 
detect a significant difference or exclusion of a 
lack of difference between the 3 groups 
 
Conclusion 
•  In this series, patients with VMHNC and nodal 
size > 46mm appear to be a high-risk group for 
the need of re-planning during a course of 
definitive radiotherapy  
•  Findings assist in determining predictive factors 
and thresholds for need of re-planning 
•  Findings will now be tested in a prospective 
adaptive RT study   
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